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Summary Takotsubo cardiomyopathy (TCM) is a poorly understood condition in
which patients with chest pain have a transient ampulla-shaped abnormality of the
left ventriculogram, and intact coronary arteries. We report TCM in combination withAutoimmune
polyendocrine syndrome
II;
Hypothyroidism;
autoimmune polyendocrine syndrome type II (APS II), which raises new questions
about the pathogenesis of TCM.
© 2008 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
reserved.
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Introduction
Takotsubo cardiomyopathy (TCM) is a rare disease
that mimics acute myocardial infarction and is
named for the characteristic appearance of the left
ventriculogram, which resembles a Japanese octo-
pus trap (takotsubo). The etiology and mechanism
of this disease are obscure. In this report, a 64-year-
old male was diagnosed with TCM and autoimmune
polyendocrine syndrome type II (APS II). APS II, also
known as Schmidt’s Syndrome, is a rare endocrine
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doi:10.1016/j.jjcc.2008.08.005isorder in which Addison’s disease coexists with
utoimmune thyroid disease, or type 1 diabetes
ellitus, or both. Coexistence of TCM and APS II in
his patient suggests the possibility that hormonal
reconditioning may play a role in the pathogenesis
f TCM. Recurrent hypotension and hypoglycemia,
hich are frequently seen in APS II, could be the
mportant triggers of TCM.ase report
64-year-old male with a history of hypothyroidism
resented to another hospital with severe fatigue
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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Sakotsubo cardiomyopathy associated with autoimm
nd cachexia. He was admitted to the hospital
here the diagnosis of hypothyroidism was made.
hyroid hormone supplementation and hyperali-
entation were initiated in the hospital. On the
ixth hospital day, he developed fever, chest pain,
nd hypotension with a systolic blood pressure of
0mmHg. Dopamine infusion was started intra-
enously to maintain blood pressure. The ECG was
emarkable for acute myocardial infarction and
loodwork was remarkable for an elevated creati-
ine kinase of 1722 IU/l (normal range: 53—288 IU/l)
t the eighth hospital day, and subsequently he was
ransferred to our hospital for further evaluation
nd treatment.
On admission, his systolic blood pressure was
00mmHg on a continuous dopamine infusion, and
entral venous pressure was 2 cmH2O. The physical
xamination revealed a short, cachectic body habi-
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Figure 1 Electrocardiopolyendocrine syndrome II 307
us, coarse facial features, sunken eyes, alopecia,
itiligo, and a female hair distribution. An elec-
rocardiogram (Fig. 1) showed sinus rhythm with
longated Q—T intervals and ST-segment eleva-
ion in leads I, II, III, aVF, and V2—V6. Terminal T
ave inversion was seen in all leads. On transtho-
acic echocardiogram, he had severely reduced left
entricular contraction at the apical side. Car-
iac catheterization demonstrated intact coronary
rteries and left ventriculogram showed apical bal-
ooning typical for TCM (Fig. 2).
Laboratory investigations revealed mild eleva-
ion of cardiac enzymes; CK-MB peaked at 5.1U/l.
erum electrolytes revealed sodium 119mEq/l,
otassium 4.0mEq/l, chloride 96mEq/l, calcium
.8mg/dl, and phosphate 2.8mg/dl. Endocrine
esting was undertaken in response to the elec-
rolyte disorders (Table 1). Free triiodothyronine
gram on admission.
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(FT3) and free thyroxine (FT4) were suppressed,
and thyrotropin (TSH) was elevated. Basal levels of
serum catecholamines (noradrenaline, adrenaline,
and dopamine) were not increased.
Basal levels of serum cortisol, aldosterone,
and adrenocorticotropic hormone (ACTH) were
marginally within normal ranges. Cortisol response
to ACTH stimulation test was blunted (Table 2).
Antibody panels revealed high levels of anti-
thyroglobulin antibodies and anti-thyroid per-
oxidase antibodies conﬁrming a diagnosis of
Hashimoto’s disease. He sustained two episodes
Table 1 Results of endocrine and thyroid antibody
examinations
Normal range
GH (ng/ml) 0.05 0.03—0.33
LH (mIU/ml) 0.9 0.8—5.7
FSH (mIU/ml) 1.5 2.0—8.3
PRL (ng/ml) 2.6 3.6—12.8
PTH (pg/ml) 4.8 10.0—65.0
FT4 (ng/dl) 0.41 1.00—1.80
FT3 (pg/ml) 1.41 2.20—4.40
TSH (U/ml) 8.25 0.27—4.20
TBG (g/ml) 29.2 12.0—28.0
Tg Ab (U/ml) 11.5 0.0—32.7
TPO Ab (U/ml) >60 0.00—0.30
Adrenaline <0.01 0.00—0.10
Noradrenaline 0.16 0.10—0.50
Dopamine <0.01 0.00—0.03
GH, growth hormone; LH, luteinizing hormone; FSH, follicle
stimulating hormone; PRL, prolactin; PTH, parathyroid hor-
mone; FT4, free thyroxine; FT3, free triiodothyronine; TSH,
thyrotropin; TBG, thyroid binding globulin; Tg Ab, thyroglob-
ulin antibody; TPO Ab, thyroid peroxidase antibody.
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f hypoglycemia, in which his serum glucose was
60mg/dl, further fulﬁlling the criteria for the
iagnosis of APS II, but was not diagnosed with frank
ype I diabetes.
He was treated with corticosteroids, thyroid hor-
one, and -blockade. Left ventricular wall motion
ecovered by the sixth hospital day, and he did well
hereafter.
iscussion
his case reports the coexistence of TCM and APS
I in a single patient. TCM remains an enigmatic
isorder. Various precipitating factors have been
roposed [1]: emotional stress [2], severe phys-
cal stress, surgery, medication withdrawal [3],
eneral anesthesia [4], natural disasters [5], thyro-
oxicosis [6], multiple endocrine neoplasia [7], and
ypoglycemic attacks [8,9]. Tsuchihashi et al. [1]
uggested that emotional and physical stress play
n important role in TCM. Linking these etiologies,
rora et al. [10] suggested that the TCM results
rom catecholamine cardiotoxicity, a hypothesis
upported by other authors [2,11].
TCM has been reported with hypoglycemic coma
n elderly women and with anorexia nervosa,
oth situations in which catecholamines are ele-
ated [9]. Episodes of excessive catecholamine
elease under such stressful conditions could trig-
er TCM after hypoglycemia. This patient was both
olume-depleted (low central venous pressure) and
ypoglycemic due to APS II. When he was admitted,
erum catecholamines were not increased despite
he above situation. Because there was no disor-
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Table 2 Results of ACTH stimulating test
Before test 30min after test Normal range
Aldosterone (ng/dl) <1 10.7 3.6—24.0
Cortisol (g/dl) 1.0 3.3 4.5—21.1
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ACTH, adrenocorticotropic hormone.
er of the adrenal medulla in this patient, the
ack of an increase in catecholamine excretion was
nreasonable. Persisting transient intrinsic cate-
holamine overshoot in response to hypotension or
ypoglycemia before TCM may be possible. Exter-
al dopamine infusion to maintain blood pressure
as another possibility as a triggering factor of
CM.
Hormonal dysfunction may play a role in increas-
ng the susceptibility of patients to TCM under
tressful conditions. TCM has higher prevalence
mong postmenopausal women [12,13], and women
ith anorexia nervosa [9]. Other reports have spec-
lated that hormones such as estrogen [14,15] and
asopressin [16] play a role in susceptibility to TCM.
The association between TCM and APS II is still
nknown. Catecholamine levels in APS II have never
een described. Catecholamine deﬁcit can be seen
n Bradbury—Eggleston syndrome and dopamine -
ydroxylase deﬁciency, but has not been part of any
eported APS. On the other hand, animal data sug-
est that adrenocortical androgens from the zona
eticularis may induce medullary catecholamine
ynthesis [17], but no relationship to cortisol levels
as ever been demonstrated.
This patient had a complicated endocrinopa-
hy with signiﬁcant thyroid and adrenal deﬁcits,
nd a physical examination consistent with long-
tanding hypogonadism. TCM has been reported
nce in a patient with adrenal insufﬁciency and
ypothyroidism [18], once with secondary adrenal
nsufﬁciency due to isolated ACTH deﬁciency [19],
ut not in association with isolated hypothyroidism.
here has been a single report of reversible his-
ological injury to the myocardium in a patient
ith APS II [20]. Severe hyponatremia was also
ostulated as a cause of functional reduced con-
ractility resulting from increased intracellular
alcium concentration due to dysfunction of mem-
rane sodium/calcium ion pump [19]. The theory of
ransient dysfunction of the sodium/calcium pump
ue to hyponatremia as a cause of reversible left
entricular function of TCM might be attractive;
owever, this theory could not explain segmental
entricular dysfunction in TCM.
The role of APS II in this case is not clear, but
he multiple stimuli to catecholamine synthesis or11.1 7.4—55.7
xternal dose of catecholamine may have been
mportant, or perhaps there was some hormonal
reconditioning that promoted the occurrence of
CM during hypotensive or hypoglycemic attacks.
onclusions
case in which a patient with TCM in the setting
f chronic APS II raises important questions about
he possible inﬂuence of hormonal preconditioning,
nd the interplay between hormones of the adrenal
ortex and the adrenal medulla. More detailed eval-
ation of hormone levels in TCM may bring new
nsight into this unusual and poorly understood con-
ition.
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